Showing results (91-100 of 510) with videos related to

Sort By:
Pageof 51
Folia Neuropathologica|January 1, 1997
Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's diseaseE Bertrand, W Lechowicz, G M Szpak, et al.
Urology|November 24, 1999
Burch colposuspension: long-term results and review of published reportsJ Drouin, J Tessier, P E Bertrand, et al.
Journal of Molecular Biology|January 20, 1987
Promoter properties and negative regulation of the uvrA gene by the LexA repressor and its amino-terminal DNA binding domainE Bertrand-Burggraf, S Hurstel, M Daune, et al.
International Journal of Epidemiology|September 1, 1988
Differential correlates of nutritional status in Kinshasa, ZaireW E Bertrand, N B Mock, R R Franklin
Leukemia|March 14, 2008
HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemiaJ T Whelan, D L Ludwig, F E Bertrand
Bulletin of the World Health Organization|January 1, 1984
The impact of oedema on anthropometric measurements in nutritional surveys: a case study from ZaireR R Franklin, L N Dikassa, W E Bertrand
Biophysical Chemistry|July 30, 2013
The pH dependence of staphylococcal nuclease stability is incompatible with a three-state denaturation modelDaniel Spencer, García-Moreno E Bertrand, Wesley E Stites
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 14, 2019
Teledermatology Outcomes in the Providence Veterans Health AdministrationSylvie E Bertrand, Martin A Weinstock, Shoshana M Landow
Neurologia I Neurochirurgia Polska|March 1, 1997
[Current views on the mechanisms of dopaminergic neuron death of the nigrostriatal system in Parkinson's disease]E Bertrand, W Lechowicz, G M Szpak, et al.
Circulation|January 19, 2000
Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial InvestigatorsM E Bertrand, E Esplugas, J Piessens, et al.
Pageof 51